Derivative exercise or conversion — not an open-market buy.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$7.09M of ROIV shares in the open market
Traded Jun 30, 2026 · Filed Jul 1, 2026
- ~$7.09M
- Reported value · 200K sh @ $35.45
- 1.75M
- Holds after · shares reported
- +1.1%
- stock since the trade · S&P 500 +3.8%, $35.39 → $35.78 on Oct 5
Why it stands out
A board member of Roivant Sciences sold $7.09M of Roivant Sciences shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 30, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 1, 2026
Director$1M+
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$7,090,000
Shares × reported transaction price
- Timing vs results
41 days after results of May 20, 2026, 37 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Planned / mechanical clue